而辅助性化疗的价值存在争议。
来自于胰腺癌欧洲研究小组的这篇报导发现:采用辅助性化疗有利于延长存活期,而采用辅助性的化放疗却达不到同样的效果。
While this report from the European Study Group for Pancreatic Cancer showed a survival benefit with adjuvant chemotherapy, there was no such benefit for adjuvant chemoradiotherapy.
术中或术后早期应给辅助性腹腔内化疗,并配合放疗及BRM辅助治疗。
Intraoperative or postoperative adjuvant to be intraperitoneal chemotherapy, and radiotherapy and BRM with adjuvant therapy.
应用推荐